We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · July 06, 2020

Low-Dose Bisphosphonates Associated With Longer Survival in Older Women With Early-Stage Breast Cancer



Additional Info

Survival in Older Women With Early Stage Breast Cancer Receiving Low-Dose Bisphosphonates or Denosumab
Cancer 2020 Jun 23;[EPub Ahead of Print], ME Suarez-Almazor, R Herrera, X Lei, M Chavez-MacGregor, H Zhao, SH Giordano

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading